It’s Thursday in the UK, so that means time for another root and branch reform of medical training. If you’re not keen on the Greenaway Report (Shape of Training review) [1], don’t fret there’ll be another one along well before...
Currently, radiotherapy and chemotherapy is the most common modality used in the management of primary head and neck squamous cell carcinomas (HNSCC). Unfortunately, around 50% of patients experience disease recurrence (rHNSCC). Surgery is therefore often used as a salvage treatment....
As our understanding of the pathophysiology of CRS evolves, so do our treatment strategies. It is accepted that in many cases, the main role of surgery is to allow better penetration of topical therapies to the sinus cavities. What, then,...
The authors argue that the current Barany criteria (ICVD) for vestibular migraine (definite and probable – dVM and pVM) are too restrictive. For instance, whereas a category of chronic migraine with or without aura is recognised in ICHD-3, ‘chronic VM’...
This is the second edition of this reference work which was first published in 2008. Vestibular assessment and management has moved on in the intervening seven years and this new edition reflects this. This aims to be a comprehensive reference...
There is growing awareness that hearing loss is linked to dementia [1]. The average first-time hearing aid user is about 70 years old. By this age, approximately 1 in 2 people have hearing loss and 1 in 7 have cognitive...
Amy Campbell, ST5 Otorhinolaryngology at Ninewells Hospital in DundeeThis year’s Scottish International Head and Neck Conference was an example of a truly successful hybrid course. It was hosted by the conference chair, Jai Manick, and co-organiser Omar Hilmi, and in...
We all have patients who give us a ‘heartsink’ feeling; for many of us, the coughing patient is exactly such a situation. In this overview, Bhaskar Ram and Sangeeta Maini outline their approach to diagnosis. Declan Costello, Editor. Introduction Chronic...
British Medical Laser Association (BMLA) held its 39th annual conference, the first in-person gathering following the COVID-19 pandemic, in the academic surrounding of the Surgeons’ Quarters of the Royal College of Surgeons in Edinburgh. Chris Henson caught up with 87-year-old...
Neuromod Devices, the medical device company specialising in tinnitus, has published the results of its TENT-A2 (Treatment Evaluation of Neuromodulation for Tinnitus – Stage A2) clinical trial in the scientific journal, Nature – Scientific Reports in a paper titled ‘Different bimodal neuromodulation settings reduce tinnitus symptoms in a large randomized trial’.
The surgical aspect of cochlear implantation is both a joy and a challenge – which is why we love it! In this article, Simon Freeman draws on the wisdom of his three previous mentors, sharing pearls from some of the...
Dr Bec Anning, SET2 Otolaryngology Trainee, New South Wales, AustraliaThis March, delegates and experts from around the world joined us on the traditional lands of the Gadigal people of the Eora Nation, for the 75th ASOHNS Annual Scientific Meeting. The...